AJP Editors Highlight Favorites Published in 2017
Abstract
The publication in 2017 of a historical perspective on Emil Kraeplin and a study assessing the mechanism of premenstrual dysphoric disorder were picked as personal favorites by AJP editors.
At the end of every year, the editors of the American Journal of Psychiatry each highlight an article of the past 12 months that they find interesting or relevant on a personal level. As AJP Editor Robert Freedman, M.D., told Psychiatric News, these year-end picks give the editors an opportunity to showcase studies in their field of expertise that deserve a second look or reflect on topics outside of their editorial area.
![Graphic: AJP cover Graphic: AJP cover](/cms/10.1176/appi.pn.2018.1b22/asset/images/medium/ajp_jan_cover.png)
“I am a general psychiatrist, but I picked a paper on childhood depression, whereas Dr. John Rush, who specializes in affective disorders, stayed close to form and picked an SSRI article,” Freedman said.
Freedman’s 2017 selection was a review from John Walkup, M.D., that contrasted the data obtained from industry- versus NIMH-funded studies of antidepressants in children, while Rush selected a piece of original research that used U.S. poison control center data to compare morbidity and mortality indices of SSRIs with other medications used to treat depression.
The other 2017 picks included a worldwide meta-analysis of brain images from people with obsessive-compulsive disorder (chosen by Daniel Pine, M.D.); an epidemiological study of where and to whom early psychosis manifests in eastern England (chosen by Carol Tamminga, M.D.); a review of the available data on whether hypnotics can increase suicide risk (chosen by Susan Schultz, M.D.); a cleverly designed clinical trial that uncovered the mechanistic basis of premenstrual dysphoric disorder (chosen by David Lewis, M.D.); and a historical article on the evolution of psychiatric diagnosis that occurred at the end of the 19th century (chosen by Robert Michels, M.D.).
And as always, the 2017 Editors’ picks included a selection from the AJP Residents’ Journal. This year, Rachel Katz, M.D., highlighted an article from resident Corey Williams, M.D., on his perspective of being an African-American psychiatrist working in mostly urban centers.
American Journal of Psychiatry Editors’ Picks for 2017
Boedhoe PSW, Schmaal L, Abe Y, et al. Distinct Subcortical Volume Alterations in Pediatric and Adult OCD: A Worldwide Meta- and Mega-Analysis. January 2017.
Kendler KS, Engstrom EJ. Kahlbaum, Hecker, and Kraepelin and the Transition From Psychiatric Symptom Complexes to Empirical Disease Forms. February 2017.
Kirkbride JB, Hameed Y, Ankireddypalli G, et al. The Epidemiology of First-Episode Psychosis in Early Intervention in Psychosis Services: Findings From the Social Epidemiology of Psychoses in East Anglia (SEPEA) Study.
McCall WV, Benca RM, Rosenquist PB, et al. Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA. January 2017.
Nelson JC, Spyker DA. Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014. May 2017.
Schmidt PJ, Martinez PE, Nieman LK, et al. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels but Not Continuous Stable Levels. October 2017.
Walkup JT. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies. May 2017.
Williams JC. Luke Cage and Police Brutality. Residents’ Journal: A Publication of the American Journal of Psychiatry. August 2017. ■
AJP’s “2017 in Review” can be accessed here.